Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Revenue

In the year 2024, Iovance Biotherapeutics had annual revenue of $164.07M with 13,698.99% growth. Iovance Biotherapeutics had revenue of $73.69M in the quarter ending December 31, 2024, with 15,189.21% growth.

• Revenue (ttm): $164.07M
• Revenue Growth: +13,698.99%
• P/S Ratio: 6.25
• Revenue / Employee: $195,788
• Employees: 838
• Market Cap: 1.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	164.07M	162.88M	13,698.99%
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.